BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2896496)

  • 21. Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls.
    Sugimura H; Caporaso NE; Shaw GL; Modali RV; Gonzalez FJ; Hoover RN; Resau JH; Trump BF; Weston A; Harris CC
    Carcinogenesis; 1990 Sep; 11(9):1527-30. PubMed ID: 1976046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?
    Nebert DW
    Am J Hum Genet; 1997 Feb; 60(2):265-71. PubMed ID: 9012398
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of pharmacogenetics in psychopharmacotherapy].
    Gram LF
    Encephale; 1991; 17 Spec No 1():123-5. PubMed ID: 1864259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P450 in Pharmacogenetics: An Update.
    Tornio A; Backman JT
    Adv Pharmacol; 2018; 83():3-32. PubMed ID: 29801580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6.
    Heim MH; Meyer UA
    Genomics; 1992 Sep; 14(1):49-58. PubMed ID: 1358797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity.
    Llerena A; Dorado P; Peñas-Lledó EM
    Pharmacogenomics; 2009 Jan; 10(1):17-28. PubMed ID: 19102711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics and drug metabolism: an Irish perspective.
    Holland P; Barry M; Feely J
    Ir J Med Sci; 1991 Feb; 160(2):54-6. PubMed ID: 1917424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tailor-made drug therapy].
    Ozawa S; Sawada J
    Nihon Rinsho; 2001 Jan; 59(1):195-201. PubMed ID: 11197856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary polymorphisms of human drug metabolizing enzymes and cancer susceptibility.
    Gonzalez FJ
    Birth Defects Orig Artic Ser; 1990; 26(1):17-42. PubMed ID: 2224077
    [No Abstract]   [Full Text] [Related]  

  • 30. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics: detecting sensitive populations.
    Shields PG
    Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):81-7. PubMed ID: 7737047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms in xenobiotic metabolism.
    Smith CA; Smith G; Wolf CR
    Eur J Cancer; 1994; 30A(13):1921-35. PubMed ID: 7734203
    [No Abstract]   [Full Text] [Related]  

  • 33. Debrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease.
    Bordet R; Broly F; Destée A; Libersa C
    Adv Neurol; 1996; 69():97-100. PubMed ID: 8615190
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer pharmacogenomics: achievements in basic research.
    Nakajima M; Yokoi T
    Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P-450IID6 phenotyping in cancer patients: debrisoquin and dextromethorphan as probes.
    Anthony LB; Boeve TJ; Hande KR
    Cancer Chemother Pharmacol; 1995; 36(2):125-8. PubMed ID: 7767948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variants of human microsomal enzymes.
    Davies DS; Boobis AR
    Biochem Soc Trans; 1983 Aug; 11(4):459-60. PubMed ID: 6617977
    [No Abstract]   [Full Text] [Related]  

  • 38. Gene-based drug prescribing: clinical implications of the cytochrome P450 genes.
    Musana AK; Wilke RA
    WMJ; 2005 Aug; 104(6):61-6. PubMed ID: 16218319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An XmnI RFLP detected with a cDNA probe for the CYP2C gene locus on chromosome 10.
    Gough AC; Spurr NK; Meehan RR; Miles JS; Wolf CR
    Nucleic Acids Res; 1989 Jun; 17(11):4426. PubMed ID: 2567989
    [No Abstract]   [Full Text] [Related]  

  • 40. Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15.
    Spurr NK; Gough AC; Stevenson K; Wolf CR
    Nucleic Acids Res; 1987 Jul; 15(14):5901. PubMed ID: 2886977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.